Overview
Company Overview

HealthAll Inc.
Strategic investors and distribution partners for platform scaling and overseas expansion
Address
Website
Class
Medical TechnologyType
Digital HealthcareIndications
-Partnering Goals
- Pharmaceutical companies and CROs for medication-adherence research and monitoring
- Healthcare and care providers for deployment, data integration and service validation
- Strategic investors and distribution partners for platform scaling and overseas expansion
Investment Info
Funding Goal
Investment is intended to expand smart pillbox deployment and sales channels, strengthen longitudinal medication-data infrastructure and quality management, develop AI-based behavioral analysis and risk prediction, and support commercialization with healthcare, pharmaceutical and international partners.
Team
Key People
Hyoungho Do
- CEO, HealthAll Inc. - Former board member of HL7 Korea. - Previously represented the ITI and PCD domains at IHE Korea. - Previously led the Technical Support Subcommittee of the Smart Health Standards Forum.
Advisors
Private
Tech & Products
Technology Details
Commercial Smart Pillbox and Monitoring System
CABINET supports medication schedules, reminders and remote monitoring through mobile and web tools. HealthAll reports V1-V3 commercialization and operating experience involving more than 2,000 users, including deployments through local governments and welfare organizations.
Longitudinal Medication-Behavior Data
The platform strategy prioritizes continuous records, reliable collection and links to prescription and health information. Pillbox access and reminder-response events provide behavioral indicators; they do not directly confirm that medication was swallowed.
FHIR and KR Core Infrastructure
HealthAll has developed FHIR server, validation and terminology tools and contributed to KR Core and patient-generated health data implementation guides. Its terminology server is listed in HL7's FHIR Terminology Ecosystem, supporting its focus on structured healthcare data exchange.
AI and B2B Service Roadmap
The roadmap targets AI medication-management commercialization in 2028, healthcare and pharmaceutical B2B expansion in 2029, and overseas Active and Assisted Living markets in 2030. Planned offerings include adherence analysis, care dashboards, monitoring subscriptions and partner APIs.
Problem & Unmet Needs
Medication Behavior Between Visits
Prescription and dispensing records offer limited visibility into medication routines at home. Time-stamped pillbox events and reminder responses can help care teams identify delays and repeated gaps in recorded activity between visits.
Fragmented Medication and Clinical Data
Medication-device records, prescriptions and clinical information often sit in separate systems. HealthAll aims to connect these data through FHIR and KR Core to support contextual analysis, care coordination and research.
Market Trends
Connected Medication Monitoring
Connected medication devices are being paired with analytics, clinical-trial monitoring and patient-support services. This provides a relevant market for HealthAll's planned expansion from device sales into recurring monitoring, analysis and API services.
Standardized Healthcare Data Exchange
FHIR and Korea's KR Core implementation guide provide common structures for exchanging healthcare information. These standards support HealthAll's strategy to connect medication-behavior records with prescription and clinical data.
Competitive Landscape
Connected Devices and Adherence Analytics
AARDEX Group combines MEMS medication-event monitoring with adherence analytics, while AdhereTech offers connected medication devices and patient-support services. HealthAll's proposed differentiation combines Korean community-care deployment experience with FHIR and KR Core capabilities.
Pipeline
Pipeline
CABINET Smart Medication Monitoring
Current Stage
Commercial Operation & ImprovementPatents & Papers
Papers
Private
Patents
Private
Certifications
Private

